Trial Profile
Single-dose Study Testing Rivaroxaban Granules for Oral Suspension Formulation in Children From 2 Months to 12 Years With Previous Thrombosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Mar 2022
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- Sponsors Bayer
- 06 Jun 2018 Status changed from recruiting to completed.
- 31 May 2018 This trial has been completed in Ireland (End date: 2018-05-22).
- 30 May 2018 This trial has been completed in Spain (End date: 2018-05-22).